Navigation Links
Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
Date:7/28/2008

Eligen(R) B12 oral formulation demonstrates 240% improvement in bioavailability versus standard oral Vitamin B12 tablet and different absorption characteristics

Eligen(R) B12 absorption time was 30 minutes

- Public Conference Call to discuss results and future direction set for July 29 -

CEDAR KNOLLS, N.J., July 28 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced new human clinical data demonstrating a new, more bioavailable oral form Vitamin B12 and a potential new avenue for addressing the problems with B12 supplementation. As demonstrated by the data, the Eligen(R) B12 formulation avoids the normal specialized absorption process that limits absorption of Vitamin B12 from current formulations.

"By circumventing the current absorption process, Eligen(R) B12 may present an opportunity to reduce the potential uncertainty associated with oral megadoses of Vitamin B12 and may prevent dependence on the substantial number of injections being taken by millions of individuals," said Michael V. Novinski, President and Chief Executive Officer of Emisphere.

Emisphere's pharmacokinetic study was conducted with 20 healthy male subjects divided into four groups - four subjects received 5mg B12 intravenously, four subjects received 10mg Eligen(R) B12, six subjects received 5mg Eligen(R) B12 and six subjects received a commercially available 5mg B12 tablet. "The 10mg Eligen(R) group served essentially as a pilot group to determine appropriate measurements and assess our protocol," said Gary Riley, DVM, Ph.D., Vice President of Nonclinical Development and Applied Biology at Emisphere. "Following these results, we reduced the amount administered by 50% to a level that is being used in
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
5. Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
6. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
10. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... July 23, 2014 This September leading clinicians ... Las Vegas for DOCtalk 2014 ... author, forward thinker and private practitioner Dr. David ... to candidly discuss clinical and practice management efficiency and ... a unique opportunity to welcome fresh thinking and join ...
(Date:7/23/2014)... 23, 2014 Global healthcare company ... facing currency headwinds, increased price competition and supply disruptions ... Andrew Witty points out that the company is very ... reason to be confident about long-term prospects as well ... CFO Simon Dingemans adds that ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
(Date:7/23/2014)... 2014 A Forever Recovery, an open-ended ... to a great start and gives them a solid ... a new Internet Addiction section of its website at ... learn that Internet addiction is not just as legitimate ... that it’s trapping more and more victims each year ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Adipic ... which is mainly a high-performance plastic, often referred ... range of materials, depending on the monomers employed. ... the automotive industry and the increasing number of ... adipic acid market share, followed by Europe and ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Children and teens who lose ... death in adulthood, a new study suggests. People who ... 50 percent greater risk of death during the study period ... parent, according to the report. Although the study found ... risk of premature death, it wasn,t designed to prove cause-and-effect. ...
(Date:7/23/2014)... For critically ill patients arriving at the emergency ... sedation and amnesia for rapid, life-saving intubation, despite ... The results of a systematic review of ... regard as a "wonder drug" are published online ... The Effect of Ketamine on Intracranial and Cerebral ...
(Date:7/23/2014)... July 23, 2014 SafeUseNow? ... intervention program developed by Principled Strategies , ... HealthPlan of California . Utilizing SafeUseNow’s patent-pending risk ... risk of misusing and abusing controlled substance drugs, ... addiction among its members. , The agreement with ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
... Ind., Nov. 21 Symmetry Medical Inc. (NYSE: SMA ... device industry and other medical markets, announced today that Brian S. ... Vice President and Chief Financial Officer, are scheduled to present at ... York Palace Hotel on Wednesday, December 3, 2008 at 12:30 p.m. ...
... smoking will receive big prizes during a special on-ice presentation ... Energy Center. The winners,were participants in The QuitCash Challenge, a ... The grand prize winner will ... cards from Gander Mountain. , ...
... study suggests , , FRIDAY, Nov. 21 (HealthDay News) -- The ... of asthma, new research suggests. , Babies born in autumn -- ... have almost a 30 percent increased risk of asthma compared to ... in the first December issue of the American Journal of ...
... Just three days after the,JUPITER trial results were presented ... by the New England Journal of Medicine, an,AlphaDetail survey ... anticipate a 14% increase in the use of drug ... risk patients. , ...
... travel nationwide to,ten top locations for Indoor Cycling / ... of innovative cycling training DVDs. The DVDs utilize,first-person ... selectable vocal coaching from industry experts. Sally Edwards,Ironman ... Matty Reed, US,triathlete champion and Olympian are just a ...
... Draeger Safety, Inc., located in,Pittsburgh PA, and ... products,provider, is countering what it believes are unsubstantiated ... of a patent,infringement on the popular Draeger PSS7000 ... Draeger has a ...
Cached Medicine News:Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Physicians Anticipate Higher Prescribing Based on JUPITER Study 2Health News:Global Ride Tours Best 12 Cities for SPINNING(R) or Indoor Cycling 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
5.5 pointed curved blade. Octagonal handle....
3 mm curved blade. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: